Both in Surgical Instruments
ResMed vs Solventum
Over the past year RMD returned −6.4% and SOLV returned +24.1%; their daily moves had a correlation of 0.43.
RMD −6.4% SOLV +24.1%Growth of $1, one year, split-adjusted
| Metric | RMD | SOLV |
|---|---|---|
| Price | $233.09 | $84.54 |
| Market cap | $32.79B | $14.39B |
| Today | +1.37% | +3.95% |
| 1 month | +6.5% | −3.8% |
| 6 months | +11.3% | +25.4% |
| Year to date | −3.2% | +6.7% |
| 1 year | −7.6% | +22.0% |
| Revenue growth (YoY) | +5.9% | +2.2% |
| Gross margin | 61.5% | 58.2% |
| Net margin | 29.6% | 4.2% |
| P/E (TTM) | 20.6× | 10.0× |
| Price / sales | 5.7× | 1.7× |
| Net cash | $601.1M | -$4.88B |
| Dividend yield | 1.13% | — |
| Volatility (60d) | 31.2% | 23.0% |
| Short % of float | 8.5% | 3.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).